Search Results 1 – 20 of 57
Pre-exposure Prophylaxis (PrEP) to Reduce the Risk of Acquiring HIV During Periconception, Antepartum, and Postpartum Periods
HHS Adults and Adolescents Antiretroviral Guidelines Panel Recommendation for the Long-Acting Injectable Antiretroviral Regimen of Cabotegravir and Rilpivirine
Preconception Counseling and Care for Women of Childbearing Age Living with HIV
Appendix B: Supplement: Safety and Toxicity of Individual Antiretroviral Agents in Pregnancy
Guidelines Panel Members
Limitations to Treatment Safety and Efficacy
Considerations for Antiretroviral Use in Patients with Coinfections
Appendix A: Key to Acronyms
Antepartum Care
Appendix B: Drug Characteristics Tables
Appendix A: Pediatric Antiretroviral Drug Information
Appendix B: Acronyms
Laboratory Testing
Management of the Treatment-Experienced Patient
Management of Medication Toxicity or Intolerance
Management of Children Receiving Antiretroviral Therapy
Management of Infants Born to Women with HIV Infection
Drug-Drug Interactions
Introduction
Introduction